<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02334215</url>
  </required_header>
  <id_info>
    <org_study_id>3U01DA013636</org_study_id>
    <secondary_id>3U01DA013636</secondary_id>
    <nct_id>NCT02334215</nct_id>
  </id_info>
  <brief_title>A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail</brief_title>
  <acronym>SOMATICS FRI</acronym>
  <official_title>A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Friends Research Institute, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laura and John Arnold Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Friends Research Institute, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine which of three approaches started in jail is more&#xD;
      effective in treating opioid use disorder: (1) methadone treatment without counseling (termed&#xD;
      interim methadone) coupled with case management (termed patient navigation); (2) interim&#xD;
      methadone without patient navigation; (3) or an enhanced treatment as usual including opioid&#xD;
      detoxification, overdose prevention and drug treatment information and referral.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is part of the NIDA &quot;Studies of Medication for Addiction Treatment in Correctional&#xD;
      Settings (SOMATICS)&quot; U01 Collaborative. Our distinct NIH-funded study at Friends Research&#xD;
      Institute has been aligned with two other jail-based opioid treatment studies conducted by&#xD;
      researchers at New York University (NYU) and at University of California Los Angeles (UCLA).&#xD;
      SOMATICS seeks to harmonize assessments and interventions across the three research centers&#xD;
      (RCs) and the three independent studies in order to leverage power, sample size, and increase&#xD;
      the generalizability of findings. Each of the RCs in the SOMATICS cooperative will conduct&#xD;
      their own individual trial, sharing one study arm with another RC, and several core&#xD;
      assessments across all sites. The SOMATICS collaborative will have a common Statistical&#xD;
      Analysis Plan and Data and Safety Monitoring Plan (DSMP) including a single DSMB. The&#xD;
      collaborative primary and secondary outcomes across all sites are listed below:&#xD;
&#xD;
      Collaborative Primary Outcome Measure:&#xD;
&#xD;
      1. DSM-5 Opioid Use Disorder Diagnosis during the 30 days prior to the 6 months post-release&#xD;
      follow-up assessment: Measured by: modified World Mental Health Composite International&#xD;
      Diagnostic Interview.&#xD;
&#xD;
      Collaborative Secondary Outcome Measures:&#xD;
&#xD;
        1. Illicit Opioid use: measured by urine drug testing results at 6 months post-release&#xD;
&#xD;
        2. Number of days incarcerated: Measured by self-report during the 6 months post-release.&#xD;
&#xD;
        3. HIV risk behavior: Measured by self-report (Drug Risk Assessment Battery [RAB] Needle&#xD;
           Use score) at the 6-month post-release follow-up assessment.&#xD;
&#xD;
        4. Number of days of Opioids, Cocaine, Alcohol, Benzodiazepines, and/or IV Drug Use:&#xD;
           Measured by Time Line Follow Back at 6 months post-release follow-up (TLFB; NYU, UCLA)&#xD;
           and ASI (FRI).&#xD;
&#xD;
        5. Non-opioid drug use (Cocaine, Amphetamines, and Benzodiazepines): measured by urine drug&#xD;
           testing at 6 months post-release&#xD;
&#xD;
        6. Number of days in any drug abuse treatment: Measured by self-report at 6 months&#xD;
           post-release.&#xD;
&#xD;
        7. Number of arrests: Measured by self-report data collected at 6 months post-release.&#xD;
&#xD;
        8. Craving scores (for NYU and UCLA sites only): Measured by self-report craving scale at 6&#xD;
           months post-release.&#xD;
&#xD;
        9. Non-lethal overdose (Yes/No): Measured by self-report during the 6 months post-release.&#xD;
&#xD;
       10. Lethal overdose (Yes/No): Measured by public records data reviewed at 6 months&#xD;
           post-release.&#xD;
&#xD;
       11. WHO Quality of Life-BREF (WHOQOL-BREF) score: Measured by self-report at 6 months&#xD;
           post-release.&#xD;
&#xD;
       12. Analyses of above self-same outcomes at 12 months follow-up.&#xD;
&#xD;
       13. Once the primary trial is complete, the site in Baltimore will collect longer-term&#xD;
           outcome data at a 24-month follow-up point through funding from the Arnold Foundation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 15, 2014</start_date>
  <completion_date type="Actual">May 2020</completion_date>
  <primary_completion_date type="Actual">March 8, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Predicted Probability Derived From the Generalized Linear Mixed Model of Opioid Urine Test Positive Results Over Time</measure>
    <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
    <description>Predicted probability derived from the generalized linear mixed model opioid positive urine tests (0= negative; 1- positive) for heroin, oxycodone, methadone, or buprenorphine -- excluding the latter two positives when they results from prescribed medications to treat opioid use disorder)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Predicted Probability Derived From the General Linear Mixed Model of Entry Into Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form</measure>
    <time_frame>30 days post-release from incarceration</time_frame>
    <description>Predicted probability derived from the general linear mixed model of self-reported entry into treatment for opioid use disorder following release from incarceration and being in treatment 30 days post-release (0= no entry in treatment; 1= entry in treatment).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predicted Probability Derived From Generalized Linear Mixed Model of Meeting Opioid Use Disorder Criteria as Determined by the Modified Composite International Diagnostic Interview (CIDI)</measure>
    <time_frame>one month period prior to the 3, 6, and 12 month post-release from incarceration</time_frame>
    <description>Predicted probability derived from the Generalized Linear Mixed Model of meeting the Data and Statistical Manual - 5 criteria for Opioid Use Disorder in response to modified CIDI interview (0= does not meet criteria; 1= meets criteria).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Arrests</measure>
    <time_frame>one year post-release from incarceration</time_frame>
    <description>Official data on participant arrests subsequent to release from index incarceration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug Risk Score on the Risk Assessment Battery (RAB)</measure>
    <time_frame>Baseline and 6, and 12 months post-release from incarceration</time_frame>
    <description>Drug Risk Scale Score on the Risk Assessment Battery. The scale's range goes from 0 to 22. Higher score represents greater frequency of drug risk behaviors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sex Risk Score on the Risk Assessment Battery (RAB)</measure>
    <time_frame>Baseline and 6, and 12 months post-release from incarceration</time_frame>
    <description>Sex Risk Score on the Risk Assessment Battery (RAB). Higher scores represents greater risk. The score ranges from 0 to 18.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</measure>
    <time_frame>1, 3, 6, and 12 months post-incarceration</time_frame>
    <description>The score on the Physical Domain Scale of the World Health Organization Quality of Life Scale-BREF (WHOQOL-BREF). The scales range is from 0 to 100. The higher score represents better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</measure>
    <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
    <description>Scale score on the Psychological Domain on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</measure>
    <time_frame>1, 3, 6, and 12 month post-release from incarceration</time_frame>
    <description>Social domain scale score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Environmental Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</measure>
    <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
    <description>Environmental domain score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. A higher score represents a better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Quality of Life Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</measure>
    <time_frame>1, 3, 6, and 12 month post-release from incarceration</time_frame>
    <description>Self report quality of life as reported by participants following release from their index incarceration on a scale from 1 to 5. A higher score is a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predicted Probability Derived From the Generalized Linear Mixed Model of Being Retained in Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form</measure>
    <time_frame>12 months post-release from incarceration</time_frame>
    <description>Predicted Probability derived from the Generalized Linear Mixed of self-reported enrolled in treatment for Opioid Use Disorder at the time of the follow-up interview (0=not enrolled; 1=enrolled).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Number of Days of Criminal Activity in the Past 30 Days Reported by Participants on the Addiction Severity Index (ASI)</measure>
    <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
    <description>Mean number of days reported by participants of their criminal activity during the 30 days preceding the Addiction Severity Index interviews</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Number of Days of Illicit Opioid Use Reported by Participants in the Past 30 Days</measure>
    <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
    <description>Mean number of participant self-reported days of heroin use in the 30 days preceding the interview on the Addiction Severity Index (ASI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant Self-reported Mean Number of Days of Cocaine Use in the Past 30 Days</measure>
    <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
    <description>Participant self-reported mean number of days of cocaine use in the 30 days preceding the interview on the Addiction Severity Index (ASI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predicted Probability Derived From the Generalized Linear Mixed Model of Meeting Cocaine Use Disorder Criteria in the Past 30 Days</measure>
    <time_frame>3, 6, and 12 months post-release from incarceration</time_frame>
    <description>Predicted Probability Derived from the Generalized Linear Mixed Model meeting Data and Statistical Manual - 5 criteria for Cocaine Use Disorder on the modified Composite International Diagnostic Interview (CIDI) (0=Does not meet criteria; 1=meets criteria).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of Hospitalization (Health Care Utilization) on the Economic Form 90 (EF-90)</measure>
    <time_frame>12 months post-release from incarceration</time_frame>
    <description>Mean number of days hospitalized during the 12 months post-release from incarceration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of Substance Abuse Services</measure>
    <time_frame>12 months post-release from incarceration</time_frame>
    <description>Cost in US Dollars of substance abuse services on the modified Substance Abuse Services Cost Analysis Program</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">225</enrollment>
  <condition>Opioid Use Disorder</condition>
  <arm_group>
    <arm_group_label>Methadone plus Patient Navigation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methadone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will begin methadone during detention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enhanced Treatment as Usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methadone</intervention_name>
    <description>Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
    <arm_group_label>Methadone</arm_group_label>
    <arm_group_label>Methadone plus Patient Navigation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient Navigation</intervention_name>
    <description>A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
    <arm_group_label>Methadone plus Patient Navigation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced Treatment as Usual (ETAU)</intervention_name>
    <description>Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
    <arm_group_label>Enhanced Treatment as Usual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1) Meets Diagnostic and Statistical Manual -5 (DSM-5) criteria for opioid use&#xD;
             disorder; (2) detained for at least 48 hours; (3) receiving opioid withdrawal&#xD;
             treatment (as-usual) through the Detention Center's medical providers; (4) able and&#xD;
             willing to provide informed consent in English; (5) detained for a charge that, if&#xD;
             found guilty, will result in a sentence of less than 1 year; (6) plan to reside in&#xD;
             Baltimore upon release; (7) 18 years of age and older.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  (1) enrolled in methadone or buprenorphine treatment in the community at the time of&#xD;
             arrest; (2) having a medical (liver failure, congestive heart failure) or psychiatric&#xD;
             condition (e.g., suicidal ideation, psychosis) that would make participation unsafe in&#xD;
             the judgment of the medical staff or the PI; (3) pregnancy; (4) allergy to methadone;&#xD;
             and, (5) requiring treatment for alcohol or sedative hypnotic withdrawal.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Baltimore City Detention Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 26, 2014</study_first_submitted>
  <study_first_submitted_qc>January 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2015</study_first_posted>
  <results_first_submitted>May 26, 2020</results_first_submitted>
  <results_first_submitted_qc>September 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 16, 2020</results_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Opioid-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methadone</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 9, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT02334215/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Methadone Plus Patient Navigation</title>
          <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
        </group>
        <group group_id="P2">
          <title>Methadone</title>
          <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
        </group>
        <group group_id="P3">
          <title>Enhanced Treatment as Usual</title>
          <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="74"/>
                <participants group_id="P3" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
                <participants group_id="P2" count="68"/>
                <participants group_id="P3" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Not released from incarceration on time</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Incarcerated</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Methadone Plus Patient Navigation</title>
          <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
        </group>
        <group group_id="B2">
          <title>Methadone</title>
          <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
        </group>
        <group group_id="B3">
          <title>Enhanced Treatment as Usual</title>
          <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
            <count group_id="B2" value="74"/>
            <count group_id="B3" value="76"/>
            <count group_id="B4" value="225"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.6" spread="10.0"/>
                    <measurement group_id="B2" value="37.3" spread="10.0"/>
                    <measurement group_id="B3" value="37.9" spread="11.1"/>
                    <measurement group_id="B4" value="38.3" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="61"/>
                    <measurement group_id="B4" value="181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="73"/>
                    <measurement group_id="B4" value="219"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="139"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="56"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="76"/>
                    <measurement group_id="B4" value="225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Predicted Probability Derived From the Generalized Linear Mixed Model of Opioid Urine Test Positive Results Over Time</title>
        <description>Predicted probability derived from the generalized linear mixed model opioid positive urine tests (0= negative; 1- positive) for heroin, oxycodone, methadone, or buprenorphine -- excluding the latter two positives when they results from prescribed medications to treat opioid use disorder)</description>
        <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
        <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, incarcerated individuals who were not drug tested, people interviewed by phone because they no longer lived in the area).</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Predicted Probability Derived From the Generalized Linear Mixed Model of Opioid Urine Test Positive Results Over Time</title>
          <description>Predicted probability derived from the generalized linear mixed model opioid positive urine tests (0= negative; 1- positive) for heroin, oxycodone, methadone, or buprenorphine -- excluding the latter two positives when they results from prescribed medications to treat opioid use disorder)</description>
          <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, incarcerated individuals who were not drug tested, people interviewed by phone because they no longer lived in the area).</population>
          <units>Probability</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
                <count group_id="O2" value="68"/>
                <count group_id="O3" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 month post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="53"/>
                    <count group_id="O3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.70" spread="0.08"/>
                    <measurement group_id="O2" value="0.72" spread="0.09"/>
                    <measurement group_id="O3" value="0.66" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="50"/>
                    <count group_id="O2" value="43"/>
                    <count group_id="O3" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.59" spread="0.08"/>
                    <measurement group_id="O2" value="0.72" spread="0.09"/>
                    <measurement group_id="O3" value="0.73" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="52"/>
                    <count group_id="O2" value="44"/>
                    <count group_id="O3" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.49" spread="0.09"/>
                    <measurement group_id="O2" value="0.63" spread="0.10"/>
                    <measurement group_id="O3" value="0.71" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="46"/>
                    <count group_id="O3" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.46" spread="0.08"/>
                    <measurement group_id="O2" value="0.71" spread="0.09"/>
                    <measurement group_id="O3" value="0.59" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone arms compared to Enhanced Treatment as Usual</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.32</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.32</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Predicted Probability Derived From the General Linear Mixed Model of Entry Into Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form</title>
        <description>Predicted probability derived from the general linear mixed model of self-reported entry into treatment for opioid use disorder following release from incarceration and being in treatment 30 days post-release (0= no entry in treatment; 1= entry in treatment).</description>
        <time_frame>30 days post-release from incarceration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Predicted Probability Derived From the General Linear Mixed Model of Entry Into Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form</title>
          <description>Predicted probability derived from the general linear mixed model of self-reported entry into treatment for opioid use disorder following release from incarceration and being in treatment 30 days post-release (0= no entry in treatment; 1= entry in treatment).</description>
          <units>Probability</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" spread="0.09"/>
                    <measurement group_id="O2" value="0.62" spread="0.10"/>
                    <measurement group_id="O3" value="0.225" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Contrast of Interest: Methadone plus Patient Navigation and Methadone Conditions combined vs. Enhanced Treatment as Usual Conditions</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.001</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Enhanced Treatment as Usual</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.84</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Predicted Probability Derived From Generalized Linear Mixed Model of Meeting Opioid Use Disorder Criteria as Determined by the Modified Composite International Diagnostic Interview (CIDI)</title>
        <description>Predicted probability derived from the Generalized Linear Mixed Model of meeting the Data and Statistical Manual - 5 criteria for Opioid Use Disorder in response to modified CIDI interview (0= does not meet criteria; 1= meets criteria).</description>
        <time_frame>one month period prior to the 3, 6, and 12 month post-release from incarceration</time_frame>
        <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 30 days prior to the interview).</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Predicted Probability Derived From Generalized Linear Mixed Model of Meeting Opioid Use Disorder Criteria as Determined by the Modified Composite International Diagnostic Interview (CIDI)</title>
          <description>Predicted probability derived from the Generalized Linear Mixed Model of meeting the Data and Statistical Manual - 5 criteria for Opioid Use Disorder in response to modified CIDI interview (0= does not meet criteria; 1= meets criteria).</description>
          <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 30 days prior to the interview).</population>
          <units>Probability</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
                <count group_id="O2" value="68"/>
                <count group_id="O3" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.66" spread="0.09"/>
                    <measurement group_id="O2" value="0.70" spread="0.08"/>
                    <measurement group_id="O3" value="0.76" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" spread="0.09"/>
                    <measurement group_id="O2" value="0.59" spread="0.09"/>
                    <measurement group_id="O3" value="0.77" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.54" spread="0.09"/>
                    <measurement group_id="O2" value="0.77" spread="0.11"/>
                    <measurement group_id="O3" value="0.59" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone Conditions combined vs. Enhanced Treatment as Usual</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.11</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.55</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Arrests</title>
        <description>Official data on participant arrests subsequent to release from index incarceration.</description>
        <time_frame>one year post-release from incarceration</time_frame>
        <population>Data presented on the subset of those participants who were released from index incarceration during the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Arrests</title>
          <description>Official data on participant arrests subsequent to release from index incarceration.</description>
          <population>Data presented on the subset of those participants who were released from index incarceration during the study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
                <count group_id="O2" value="69"/>
                <count group_id="O3" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.55</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.57</p_value>
            <method>Regression, Logistic</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Drug Risk Score on the Risk Assessment Battery (RAB)</title>
        <description>Drug Risk Scale Score on the Risk Assessment Battery. The scale's range goes from 0 to 22. Higher score represents greater frequency of drug risk behaviors</description>
        <time_frame>Baseline and 6, and 12 months post-release from incarceration</time_frame>
        <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 6 months prior to the interview).</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Drug Risk Score on the Risk Assessment Battery (RAB)</title>
          <description>Drug Risk Scale Score on the Risk Assessment Battery. The scale's range goes from 0 to 22. Higher score represents greater frequency of drug risk behaviors</description>
          <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 6 months prior to the interview).</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="75"/>
                    <count group_id="O2" value="74"/>
                    <count group_id="O3" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.30" spread=".57"/>
                    <measurement group_id="O2" value="2.43" spread=".62"/>
                    <measurement group_id="O3" value="3.11" spread=".76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="62"/>
                    <count group_id="O2" value="60"/>
                    <count group_id="O3" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.52" spread=".52"/>
                    <measurement group_id="O2" value="1.81" spread=".65"/>
                    <measurement group_id="O3" value="2.16" spread=".73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month post-release</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="64"/>
                    <count group_id="O2" value="58"/>
                    <count group_id="O3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".50" spread=".25"/>
                    <measurement group_id="O2" value="1.35" spread=".59"/>
                    <measurement group_id="O3" value="1.03" spread=".44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone compared to Enhanced Treatment as Usual</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.997</p_value>
            <method>Generalized Linear Mixed Model</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.26</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sex Risk Score on the Risk Assessment Battery (RAB)</title>
        <description>Sex Risk Score on the Risk Assessment Battery (RAB). Higher scores represents greater risk. The score ranges from 0 to 18.</description>
        <time_frame>Baseline and 6, and 12 months post-release from incarceration</time_frame>
        <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 6 months prior to the interview).</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Sex Risk Score on the Risk Assessment Battery (RAB)</title>
          <description>Sex Risk Score on the Risk Assessment Battery (RAB). Higher scores represents greater risk. The score ranges from 0 to 18.</description>
          <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 6 months prior to the interview).</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="75"/>
                    <count group_id="O2" value="74"/>
                    <count group_id="O3" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.52" spread=".34"/>
                    <measurement group_id="O2" value="4.78" spread=".35"/>
                    <measurement group_id="O3" value="4.68" spread=".34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="62"/>
                    <count group_id="O2" value="60"/>
                    <count group_id="O3" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.93" spread=".34"/>
                    <measurement group_id="O2" value="3.94" spread=".35"/>
                    <measurement group_id="O3" value="4.27" spread=".36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month post-release</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="64"/>
                    <count group_id="O2" value="58"/>
                    <count group_id="O3" value="56"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.78" spread=".36"/>
                    <measurement group_id="O2" value="4.61" spread=".42"/>
                    <measurement group_id="O3" value="4.17" spread=".38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone compared to Enhanced Treatment as Usual</non_inferiority_desc>
            <p_value>.663</p_value>
            <method>Generalized Linear Mixed Model</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.33</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Physical Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
        <description>The score on the Physical Domain Scale of the World Health Organization Quality of Life Scale-BREF (WHOQOL-BREF). The scales range is from 0 to 100. The higher score represents better quality of life.</description>
        <time_frame>1, 3, 6, and 12 months post-incarceration</time_frame>
        <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Physical Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
          <description>The score on the Physical Domain Scale of the World Health Organization Quality of Life Scale-BREF (WHOQOL-BREF). The scales range is from 0 to 100. The higher score represents better quality of life.</description>
          <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="75"/>
                    <count group_id="O2" value="74"/>
                    <count group_id="O3" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.6" spread="2.8"/>
                    <measurement group_id="O2" value="58.3" spread="3.0"/>
                    <measurement group_id="O3" value="57.1" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="55"/>
                    <count group_id="O3" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.8" spread="3.0"/>
                    <measurement group_id="O2" value="62.2" spread="3.4"/>
                    <measurement group_id="O3" value="68.7" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.3" spread="3.1"/>
                    <measurement group_id="O2" value="60.1" spread="3.1"/>
                    <measurement group_id="O3" value="67.3" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="56"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.6" spread="3.1"/>
                    <measurement group_id="O2" value="66.3" spread="3.2"/>
                    <measurement group_id="O3" value="61.2" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.1" spread="3.0"/>
                    <measurement group_id="O2" value="63.8" spread="3.2"/>
                    <measurement group_id="O3" value="60.3" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone arms compared to Enhanced Treatment as Usual</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.007</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.76</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Psychological Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
        <description>Scale score on the Psychological Domain on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life.</description>
        <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
        <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Psychological Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
          <description>Scale score on the Psychological Domain on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life.</description>
          <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="75"/>
                    <count group_id="O2" value="74"/>
                    <count group_id="O3" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.8" spread="2.8"/>
                    <measurement group_id="O2" value="56.9" spread="3.0"/>
                    <measurement group_id="O3" value="55.9" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 month post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="55"/>
                    <count group_id="O3" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.5" spread="3.1"/>
                    <measurement group_id="O2" value="64.0" spread="3.5"/>
                    <measurement group_id="O3" value="66.7" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.6" spread="3.4"/>
                    <measurement group_id="O2" value="61.2" spread="3.3"/>
                    <measurement group_id="O3" value="66.6" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="56"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.9" spread="3.5"/>
                    <measurement group_id="O2" value="63.9" spread="3.6"/>
                    <measurement group_id="O3" value="64.8" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.0" spread="3.2"/>
                    <measurement group_id="O2" value="61.8" spread="3.4"/>
                    <measurement group_id="O3" value="64.4" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Enhanced Treatment as Usual</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.60</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.0</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Social Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
        <description>Social domain scale score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life.</description>
        <time_frame>1, 3, 6, and 12 month post-release from incarceration</time_frame>
        <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Social Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
          <description>Social domain scale score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life.</description>
          <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="75"/>
                    <count group_id="O2" value="55"/>
                    <count group_id="O3" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.9" spread="3.9"/>
                    <measurement group_id="O2" value="57.7" spread="4.0"/>
                    <measurement group_id="O3" value="51.3" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 month post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="74"/>
                    <count group_id="O3" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.6" spread="3.9"/>
                    <measurement group_id="O2" value="57.5" spread="4.4"/>
                    <measurement group_id="O3" value="64.9" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.9" spread="4.1"/>
                    <measurement group_id="O2" value="62.4" spread="4.0"/>
                    <measurement group_id="O3" value="66.4" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="56"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.3" spread="3.8"/>
                    <measurement group_id="O2" value="63.3" spread="3.9"/>
                    <measurement group_id="O3" value="58.8" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.6" spread="4.3"/>
                    <measurement group_id="O2" value="55.4" spread="4.5"/>
                    <measurement group_id="O3" value="59.1" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone vs. Enhanced Treatment as Usual</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.09</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.74</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Environmental Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
        <description>Environmental domain score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. A higher score represents a better quality of life.</description>
        <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
        <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Environmental Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
          <description>Environmental domain score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. A higher score represents a better quality of life.</description>
          <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="75"/>
                    <count group_id="O2" value="74"/>
                    <count group_id="O3" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.0" spread="3.0"/>
                    <measurement group_id="O2" value="54.6" spread="3.1"/>
                    <measurement group_id="O3" value="54.9" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="55"/>
                    <count group_id="O3" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.1" spread="2.9"/>
                    <measurement group_id="O2" value="63.6" spread="3.3"/>
                    <measurement group_id="O3" value="65.1" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.9" spread="3.2"/>
                    <measurement group_id="O2" value="55.1" spread="3.2"/>
                    <measurement group_id="O3" value="63.7" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="56"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.0" spread="3.3"/>
                    <measurement group_id="O2" value="60.6" spread="3.4"/>
                    <measurement group_id="O3" value="57.2" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.8" spread="3.2"/>
                    <measurement group_id="O2" value="59.4" spread="3.4"/>
                    <measurement group_id="O3" value="59.3" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone vs. Enhanced Treatment as Usual</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.013</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.71</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Quality of Life Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
        <description>Self report quality of life as reported by participants following release from their index incarceration on a scale from 1 to 5. A higher score is a better outcome.</description>
        <time_frame>1, 3, 6, and 12 month post-release from incarceration</time_frame>
        <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Quality of Life Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF)</title>
          <description>Self report quality of life as reported by participants following release from their index incarceration on a scale from 1 to 5. A higher score is a better outcome.</description>
          <population>The number analyzed at the follow-up points differ due to missing data (e.g., lost to follow-up, people who were incarcerated during the 4 weeks prior to the interview).</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="75"/>
                    <count group_id="O2" value="74"/>
                    <count group_id="O3" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="1.6"/>
                    <measurement group_id="O2" value="2.8" spread=".16"/>
                    <measurement group_id="O3" value="3.1" spread=".16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 month post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="55"/>
                    <count group_id="O3" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.49" spread=".162"/>
                    <measurement group_id="O2" value="3.56" spread=".19"/>
                    <measurement group_id="O3" value="3.40" spread=".19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.15" spread=".17"/>
                    <measurement group_id="O2" value="3.46" spread=".17"/>
                    <measurement group_id="O3" value="3.57" spread=".17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="56"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.51" spread=".17"/>
                    <measurement group_id="O2" value="3.58" spread=".18"/>
                    <measurement group_id="O3" value="3.53" spread=".17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="57"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.29" spread=".17"/>
                    <measurement group_id="O2" value="3.43" spread=".18"/>
                    <measurement group_id="O3" value="3.45" spread=".17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone vs. Enhanced Treatment as Usual</non_inferiority_desc>
            <p_value>.32</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.85</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Predicted Probability Derived From the Generalized Linear Mixed Model of Being Retained in Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form</title>
        <description>Predicted Probability derived from the Generalized Linear Mixed of self-reported enrolled in treatment for Opioid Use Disorder at the time of the follow-up interview (0=not enrolled; 1=enrolled).</description>
        <time_frame>12 months post-release from incarceration</time_frame>
        <population>Participants who had completed at least one follow-up interview.</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Predicted Probability Derived From the Generalized Linear Mixed Model of Being Retained in Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form</title>
          <description>Predicted Probability derived from the Generalized Linear Mixed of self-reported enrolled in treatment for Opioid Use Disorder at the time of the follow-up interview (0=not enrolled; 1=enrolled).</description>
          <population>Participants who had completed at least one follow-up interview.</population>
          <units>Probability</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 month post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="61"/>
                    <count group_id="O2" value="56"/>
                    <count group_id="O3" value="50"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".63" spread=".08"/>
                    <measurement group_id="O2" value=".56" spread=".09"/>
                    <measurement group_id="O3" value=".26" spread=".08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="61"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".57" spread=".08"/>
                    <measurement group_id="O2" value=".47" spread=".09"/>
                    <measurement group_id="O3" value=".19" spread=".07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="59"/>
                    <count group_id="O3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".52" spread=".09"/>
                    <measurement group_id="O2" value=".52" spread=".09"/>
                    <measurement group_id="O3" value=".24" spread=".07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="64"/>
                    <count group_id="O2" value="58"/>
                    <count group_id="O3" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".40" spread=".09"/>
                    <measurement group_id="O2" value=".27" spread=".09"/>
                    <measurement group_id="O3" value=".29" spread=".08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone vs. Enhanced Treatment as Usual</non_inferiority_desc>
            <p_value>.10</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.74</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Number of Days of Criminal Activity in the Past 30 Days Reported by Participants on the Addiction Severity Index (ASI)</title>
        <description>Mean number of days reported by participants of their criminal activity during the 30 days preceding the Addiction Severity Index interviews</description>
        <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
        <population>Participants who completed at least one follow-up interview following release from index incarceration</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Number of Days of Criminal Activity in the Past 30 Days Reported by Participants on the Addiction Severity Index (ASI)</title>
          <description>Mean number of days reported by participants of their criminal activity during the 30 days preceding the Addiction Severity Index interviews</description>
          <population>Participants who completed at least one follow-up interview following release from index incarceration</population>
          <units>Days</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 month post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="55"/>
                    <count group_id="O3" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.22" spread="1.29"/>
                    <measurement group_id="O2" value="8.18" spread="1.74"/>
                    <measurement group_id="O3" value="8.22" spread="2.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.79" spread="1.81"/>
                    <measurement group_id="O2" value="9.35" spread="1.66"/>
                    <measurement group_id="O3" value="10.59" spread="2.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.24" spread="1.88"/>
                    <measurement group_id="O2" value="9.74" spread="1.89"/>
                    <measurement group_id="O3" value="11.49" spread="1.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.88" spread="1.54"/>
                    <measurement group_id="O2" value="9.97" spread="1.88"/>
                    <measurement group_id="O3" value="10.18" spread="1.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone vs. Enhanced Treatment as Usual</non_inferiority_desc>
            <p_value>.42</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.42</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Number of Days of Illicit Opioid Use Reported by Participants in the Past 30 Days</title>
        <description>Mean number of participant self-reported days of heroin use in the 30 days preceding the interview on the Addiction Severity Index (ASI)</description>
        <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
        <population>Participants who were interviewed at least once following release from index incarceration.</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Number of Days of Illicit Opioid Use Reported by Participants in the Past 30 Days</title>
          <description>Mean number of participant self-reported days of heroin use in the 30 days preceding the interview on the Addiction Severity Index (ASI)</description>
          <population>Participants who were interviewed at least once following release from index incarceration.</population>
          <units>Days</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 month post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="55"/>
                    <count group_id="O3" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.66" spread="1.32"/>
                    <measurement group_id="O2" value="12.07" spread="1.72"/>
                    <measurement group_id="O3" value="14.88" spread="2.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.46" spread="1.84"/>
                    <measurement group_id="O2" value="15.15" spread="1.84"/>
                    <measurement group_id="O3" value="16.18" spread="2.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.56" spread="1.83"/>
                    <measurement group_id="O2" value="14.02" spread="1.90"/>
                    <measurement group_id="O3" value="15.42" spread="1.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.35" spread="1.66"/>
                    <measurement group_id="O2" value="14.70" spread="1.82"/>
                    <measurement group_id="O3" value="15.35" spread="1.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone vs. Enhanced Treatment as Usual</non_inferiority_desc>
            <p_value>.28</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.44</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participant Self-reported Mean Number of Days of Cocaine Use in the Past 30 Days</title>
        <description>Participant self-reported mean number of days of cocaine use in the 30 days preceding the interview on the Addiction Severity Index (ASI)</description>
        <time_frame>1, 3, 6, and 12 months post-release from incarceration</time_frame>
        <population>Participants who were interviewed at least once following release from index incarceration</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Participant Self-reported Mean Number of Days of Cocaine Use in the Past 30 Days</title>
          <description>Participant self-reported mean number of days of cocaine use in the 30 days preceding the interview on the Addiction Severity Index (ASI)</description>
          <population>Participants who were interviewed at least once following release from index incarceration</population>
          <units>Days</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 month post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="55"/>
                    <count group_id="O3" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.95" spread="1.29"/>
                    <measurement group_id="O2" value="9.05" spread="1.73"/>
                    <measurement group_id="O3" value="11.01" spread="2.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.83" spread="1.71"/>
                    <measurement group_id="O2" value="11.32" spread="1.93"/>
                    <measurement group_id="O3" value="11.94" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.74" spread="1.86"/>
                    <measurement group_id="O2" value="13.57" spread="2.23"/>
                    <measurement group_id="O3" value="11.94" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.60" spread="1.70"/>
                    <measurement group_id="O2" value="14.46" spread="2.19"/>
                    <measurement group_id="O3" value="12.63" spread="2.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone combined vs. Enhanced Treatment as Usual</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.61</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.72</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Predicted Probability Derived From the Generalized Linear Mixed Model of Meeting Cocaine Use Disorder Criteria in the Past 30 Days</title>
        <description>Predicted Probability Derived from the Generalized Linear Mixed Model meeting Data and Statistical Manual - 5 criteria for Cocaine Use Disorder on the modified Composite International Diagnostic Interview (CIDI) (0=Does not meet criteria; 1=meets criteria).</description>
        <time_frame>3, 6, and 12 months post-release from incarceration</time_frame>
        <population>Participants who completed at least one interview following release from index incarceration</population>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Predicted Probability Derived From the Generalized Linear Mixed Model of Meeting Cocaine Use Disorder Criteria in the Past 30 Days</title>
          <description>Predicted Probability Derived from the Generalized Linear Mixed Model meeting Data and Statistical Manual - 5 criteria for Cocaine Use Disorder on the modified Composite International Diagnostic Interview (CIDI) (0=Does not meet criteria; 1=meets criteria).</description>
          <population>Participants who completed at least one interview following release from index incarceration</population>
          <units>Probability</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".20" spread=".08"/>
                    <measurement group_id="O2" value=".32" spread=".011"/>
                    <measurement group_id="O3" value=".32" spread=".12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="53"/>
                    <count group_id="O2" value="51"/>
                    <count group_id="O3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".22" spread=".10"/>
                    <measurement group_id="O2" value=".35" spread=".12"/>
                    <measurement group_id="O3" value=".36" spread=".14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months post-release from incarceration</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".32" spread=".15"/>
                    <measurement group_id="O2" value=".40" spread=".20"/>
                    <measurement group_id="O3" value=".30" spread=".14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Contrast of interest: Methadone plus Patient Navigation and Methadone vs. Enhanced Treatment as Usual</non_inferiority_desc>
            <p_value>.71</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Contrast of interest: Methadone plus Patient Navigation vs. Methadone</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.86</p_value>
            <method>Generalized Linear Mixed Model Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days of Hospitalization (Health Care Utilization) on the Economic Form 90 (EF-90)</title>
        <description>Mean number of days hospitalized during the 12 months post-release from incarceration</description>
        <time_frame>12 months post-release from incarceration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Days of Hospitalization (Health Care Utilization) on the Economic Form 90 (EF-90)</title>
          <description>Mean number of days hospitalized during the 12 months post-release from incarceration</description>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
                <count group_id="O2" value="67"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="5.8"/>
                    <measurement group_id="O2" value="3.4" spread="9.7"/>
                    <measurement group_id="O3" value="1.2" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cost of Substance Abuse Services</title>
        <description>Cost in US Dollars of substance abuse services on the modified Substance Abuse Services Cost Analysis Program</description>
        <time_frame>12 months post-release from incarceration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone Plus Patient Navigation</title>
            <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
          </group>
          <group group_id="O2">
            <title>Methadone</title>
            <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
          </group>
          <group group_id="O3">
            <title>Enhanced Treatment as Usual</title>
            <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
          </group>
        </group_list>
        <measure>
          <title>Cost of Substance Abuse Services</title>
          <description>Cost in US Dollars of substance abuse services on the modified Substance Abuse Services Cost Analysis Program</description>
          <units>US Dollars</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
                <count group_id="O2" value="68"/>
                <count group_id="O3" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3052" spread="533"/>
                    <measurement group_id="O2" value="2377" spread="351"/>
                    <measurement group_id="O3" value="1884" spread="292"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 months following release from index incarceration</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Methadone Plus Patient Navigation</title>
          <description>Participants will begin methadone treatment during detention and will have a patient navigator for up to 3 months post-release from detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.&#xD;
Patient Navigation: A patient navigator will assist the participant for the first three months after release from jail to enter and remain in methadone treatment in the community.</description>
        </group>
        <group group_id="E2">
          <title>Methadone</title>
          <description>Participants will begin methadone during detention.&#xD;
Methadone: Interim methadone treatment (methadone without routine counseling) will be provided in jail. Methadone treatment with counseling will be continued in the community.</description>
        </group>
        <group group_id="E3">
          <title>Enhanced Treatment as Usual</title>
          <description>Participants will receive opioid detoxification during detention, as well as drug abuse education, overdose prevention education, and referral to drug abuse treatment and overdose prevention services in the community.&#xD;
Enhanced Treatment as Usual (ETAU): Participants will receive methadone detoxification, drug abuse and overdose prevention information, drug treatment and overdose prevention referral in the community.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="76"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" events="5" subjects_affected="1" subjects_at_risk="74"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E2" events="10" subjects_affected="7" subjects_at_risk="74"/>
                <counts group_id="E3" events="8" subjects_affected="4" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E2" events="10" subjects_affected="2" subjects_at_risk="74"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="74"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="74"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="74"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="74"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="74"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Non fatal overdose</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="74"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert P. Schwartz, M.D.</name_or_title>
      <organization>Friends Research Institute</organization>
      <phone>410-837-3977 ext 276</phone>
      <email>rschwartz@friendsresearch.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

